SCHEMBL10168166

SCHEMBL10168166

Cc1ccc2cc(F)ccc2[n+]1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
CYP2A6 P11509 1/20 0.40
ACHE P22303 5/20 0.39
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
APEX1 P27695 1/20 0.34
CASP1 P29466 1/20 0.34
BRCA1 P38398 1/20 0.34
HTT P42858 1/20 0.34
CASP7 P55210 1/20 0.34
HBB P68871 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.34
BACE1 P56817 1/20 0.33
TERT O14746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL383733 0.84 TERT (0.43) CYP1A2CYP2A6ACHEKDM4ELMNA
SCHEMBL10167906 0.79 CYP1A2 (0.50) CYP1A2CYP2A6KDM4EMEN1USP2
SCHEMBL26437742 0.78 CYP1A2 (0.39) CYP1A2CYP2A6ACHEKDM4EMEN1
SCHEMBL9736974 0.78 CYP1A2 (0.39) CYP1A2CYP2A6ACHEKDM4EMAPT
SCHEMBL21412991 0.73 SYNJ2 (0.46) ACHEMEN1LMNAMAPTHTT
SCHEMBL30968718 0.73 SYNJ2 (0.46) ACHEMEN1LMNAMAPTHTT
SCHEMBL13144480 0.73 ACHE (0.54) CYP1A2CYP2A6ACHEKDM4EMEN1
SCHEMBL26431685 0.71 CYP19A1 (0.31)
SCHEMBL30929898 0.70 ACHE (0.47) CYP2A6ACHEKDM4EMEN1LMNA
SCHEMBL1044982 0.70 ACHE (0.47) CYP2A6ACHEKDM4EMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1330456-B9 N8,N13 -DISUBSTITUTED QUINO[4,3,2-KL]ACRIDINIUM SALTS AS THERAPEUTIC AGENTS CANCER REC TECH LTD (GB) 2012-01-25 EP disclosed
EP-1330456-B1 N8,N13 -DISUBSTITUTED QUINO[4,3,2-KL]ACRIDINIUM SALTS AS THERAPEUTIC AGENTS CANCER REC TECH LTD (GB) 2011-06-15 EP disclosed